Parkinson's great drug experiment /
Once diagnosed with Parkinson's disease, most patients can expect a stable and active lifestyle for up to a decade-but new drugs could lengthen that period. This program follows five volunteers in the clinical trial of MitoQ, a medicine designed to slow the ailment's progress. Viewers are...
Other Authors: | Films for the Humanities & Sciences (Firm), Infobase., TVF International (Firm) |
---|---|
Format: | Video |
Language: | English |
Published: |
New York, N.Y. :
Infobase,
[2009], c2008.
|
Physical Description: |
1 streaming video file (45 min.) : sd., col., digital file. |
Subjects: |
Table of Contents:
- Incidence of Parkinson's Disease (0:59)
- What Is Parkinson's? (1:09)
- Brain Chemicals and Signals (1:23)
- Parkinson's Disease and Movement (1:17)
- New Drug for Parkinson's (1:11)
- Volunteers Test Drugs (1:01)
- Challenge of Parkinson's (1:01)
- New Drug: New Hope (1:05)
- Double-Blind Drug Study (1:00)
- Drug Test Volunteer (1:02)
- Placebo Effect (0:58)
- Drug Test Measurements (1:11)
- Scientific Breakthrough (1:24)
- Blood-Brain Barrier (1:01)
- Money for Science (1:12)
- Drug Test Dropouts (1:10)
- Test Invalidation (1:18)
- Lifestyle Changes (1:55)
- Brain Cell Death (1:48)
- Problems with Mitochondria (1:08)
- Antioxidants (0:58)
- Value of Co-Enzyme Q10 (1:05)
- Increase of Symptoms (0:59)
- Drug Trial Drop Out (1:02)
- Valid Test Data (1:01)
- Comparison of Conditions (1:49)
- Medications to Treat Symptoms (1:41)
- Return of Symptoms (1:13)
- Participant Speculation (1:59)
- Test Results: Drug Failure (2:00)
- Psychosomatic Response (1:14)
- Disappointment in Test Results (1:22)
- Need for Drug Testers (0:36)
- More to Learn About Parkinson's (2:00)